GlassScriptPhysician profile
Kenneth Breeden
NPI 1417900309
$2,248.26
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,026 · 2020: $659 · 2021: $563.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $434.69 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $317.80 | 2020-2021 | |
| Allergan, INC. | $226.85 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $178.10 | 2019-2021 | |
| Lilly USA, LLC | $156.02 | 2019-2021 | |
| Pfizer INC. | $120.22 | 2019-2020 | |
| Ipsen Biopharmaceuticals, INC | $111.79 | 2019-2021 | |
| Amgen INC. | $104.98 | 2019-2021 | |
| Biodelivery Sciences International, INC. | $87.51 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $73.49 | 2019 | |
| Merz North America, INC. | $71.02 | 2020 | |
| Abbvie INC. | $68.72 | 2021 | |
| Mdd US Operations, LLC | $62.78 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $56.19 | 2020-2021 | |
| Lundbeck LLC | $46.61 | 2020-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $36.72 | 2020 | |
| Zyla Life Sciences, INC. | $29.68 | 2019 | |
| Upsher-Smith Laboratories LLC | $23.51 | 2020 | |
| Depuy Synthes Sales INC. | $14.87 | 2019 | |
| Scilex Pharmaceuticals INC. | $14.19 | 2019 | |
| Boston Scientific Corporation | $12.52 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Breeden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.